Stay updated on Durvalumab Consolidation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Consolidation in NSCLC Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.4.3 added; several history-related sections appear removed or hidden, with updated UI for versioning.SummaryDifference14%

- Check11 days agoChange DetectedA new Study Status entry was added on 2026-02-10 and an earlier entry was removed on 2025-11-10 in the record history.SummaryDifference0.2%

- Check18 days agoChange DetectedThe new version adds multiple study locations (and their contacts) and removes several previously listed locations. This updates the geographic coverage and contact points shown in the study record.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page history shows a new revision label (v3.4.2) replacing v3.4.1, a minor site update that does not affect study data or user-facing content; to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed; no substantive content changes to the study record are visible.SummaryDifference0.1%

- Check46 days agoChange DetectedUI updates add a glossary toggle, color-coded diff highlights (green for additions, red for deletions), and a revision label (v3.4.0) with minor capitalization tweaks; the underlying study history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Durvalumab Consolidation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.